Virginia Tech scientists found that age-related memory loss stems from molecular changes in the brain. Memory decline might not be just a natural part of aging. Researchers at Virginia Tech have ...

Research from UChicago dissects how a single genetic switch helps butterflies mimic wing patterns of other species to protect ...

Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor ...

Two days after Intellia voluntarily paused dosing due to safety concerns, the regulator stepped in with an official hold that ...

Amazon has revealed plans to cut as many as 14,000 corporate jobs. According to reports, the cuts will include roles in human ...

With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the company has ...

Overview of Whole Genome Synthesis MarketThe global Whole Genome Synthesis Market is valued at USD 2.41 Billion in 2024 and is projected to reach a value of USD 12.21 Billion by 2035 at a CAGR ...

NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

LinkedIn co-founder Reid Hoffman warns that Silicon Valley's software obsession is limiting AI opportunities in healthcare ...